21.12.2012 Views

PCT/2001/21 : PCT Gazette, Weekly Issue No. 21, 2001 - WIPO

PCT/2001/21 : PCT Gazette, Weekly Issue No. 21, 2001 - WIPO

PCT/2001/21 : PCT Gazette, Weekly Issue No. 21, 2001 - WIPO

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>21</strong>/<strong>2001</strong><br />

8704 <strong>PCT</strong> <strong>Gazette</strong> - Section I - <strong>Gazette</strong> du <strong>PCT</strong> 25 May/mai <strong>2001</strong><br />

SK SL TJ TM TR TT TZ UA UG US UZ VN<br />

YU ZA ZW.<br />

(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />

UG ZW); EA (AM AZ BY KG KZ MD RU<br />

TJ TM); EP (AT BE CH CY DE DK ES FI<br />

FR GB GR IE IT LU MC NL PT SE TR); OA<br />

(BF BJ CF CG CI CM GA GN GW ML MR<br />

NE SN TD TG).<br />

Published / Publiée :(c)<br />

(51) 7 C07D 473/30, A61K 31/522, A61P 25/28<br />

(11) WO 01/36419 (13) A1<br />

(<strong>21</strong>) <strong>PCT</strong>/US00/41645<br />

(22) 27 Oct/oct 2000 (27.10.2000)<br />

(25) en (26) en<br />

(30) 09/442,151 16 <strong>No</strong>v/nov 1999 US<br />

(16.11.1999)<br />

(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />

(54) • USE OF 9-SUBSTITUTED HYPOXAN-<br />

THINE DERIVATIVES TO STIMULATE<br />

REGENERATION OF NERVOUS TIS-<br />

SUE<br />

• UTILISATION DE DERIVES D’HY-<br />

POXANTHINE 9-SUBSTITUEE AFIN<br />

DE STIMULER LA REGENERATION<br />

DES TISSUS NERVEUX<br />

(71) NEOTHERAPEUTICS, INC. [US/US];<br />

157 Technology Drive, Irvine, CA 92618<br />

(US).<br />

(for all designated States except / pour tous<br />

les États désignés sauf US)<br />

(72, 75) GLASKY, Alvin [US/US]; 11955 Lambert,<br />

Tustin, CA (US).<br />

(74) CULLMAN, Louis, C.; Oppenheimer Wolff<br />

& Donnelly LLP, 2029 Century Park East,<br />

Suite 3800, Los Angeles, CA 90067-3024<br />

(US).<br />

(81) AE AG AL AM AT AU AZ BA BB BG BR<br />

BY BZ CA CH CN CR CU CZ DE DK DM<br />

DZ EE ES FI GB GD GE GH GM HR HU<br />

ID IL IN IS JP KE KG KP KR KZ LC LK<br />

LR LS LT LU LV MA MD MG MK MN MW<br />

MX MZ NO NZ PL PT RO RU SD SE SG SI<br />

SK SL TJ TM TR TT TZ UA UG US UZ VN<br />

YU ZA ZW.<br />

(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />

UG ZW); EA (AM AZ BY KG KZ MD RU<br />

TJ TM); EP (AT BE CH CY DE DK ES FI FR<br />

GB GR IE IT LU MC NL PT SE); OA (BF BJ<br />

CF CG CI CM GA GN GW ML MR NE SN<br />

TD TG).<br />

Published / Publiée :(c)<br />

(51) 7 C07D 487/04, A61K 31/5025, 31/4985,<br />

A61P 43/00, 9/02, 11/00, 17/02, 11/06,<br />

27/16, 37/08, 29/00, 19/02, 9/10, 1/04, 17/06,<br />

9/04<br />

(11) WO 01/36420<br />

(<strong>21</strong>) <strong>PCT</strong>/JP00/07907<br />

(13) A1<br />

(22) 10 <strong>No</strong>v/nov 2000 (10.11.2000)<br />

(25) ja (26) ja<br />

(30) 11/323884 15 <strong>No</strong>v/nov 1999<br />

(15.11.1999)<br />

JP<br />

(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />

(54) • TRICYCLIC AZAINDOLIZINE<br />

DERIVATIVES HAVING AN SPLA2-<br />

INHIBITING EFFECT<br />

• DERIVES D’AZA-INDOLIZINE TRI-<br />

CYCLIQUE AYANT UN EFFET INHI-<br />

BITEUR SUR SPLA2<br />

(71) SHIONOGI & CO., LTD. [JP/JP]; 1-8,<br />

Doshomachi 3-chome, Chuo-ku, Osaka-shi,<br />

Osaka 541-0045 (JP).<br />

(for all designated States except / pour tous<br />

les États désignés sauf US)<br />

(72, 75) FUJI, Masahiro [JP/JP]; Shionogi<br />

& Co., Ltd., 12-4, Sagisu 5-chome,<br />

Fukushima-ku, Osaka-shi, Osaka 553-0002<br />

(JP). OKADA, Tetsuo [JP/JP]; Shionogi<br />

& Co., Ltd., 12-4, Sagisu 5-chome,<br />

Fukushima-ku, Osaka-shi, Osaka 553-0002<br />

(JP). ADACHI, Makoto [JP/JP]; Shionogi<br />

& Co., Ltd., 12-4, Sagisu 5-chome,<br />

Fukushima-ku, Osaka-shi, Osaka 553-0002<br />

(JP).<br />

(74) YAMAUCHI, Hideaki et al. / etc.; Shionogi<br />

& Co., Ltd. Intellectual Property Dept., 12-4,<br />

Sagisu 5-chome, Fukushima-ku, Osaka-shi,<br />

Osaka 553-0002 (JP).<br />

(81) AE AG AL AM AT AU AZ BA BB BG BR<br />

BY BZ CA CH CN CR CU CZ DE DK DM<br />

DZ EE ES FI GB GD GE GH GM HR HU ID<br />

IL IN IS JP KE KG KR KZ LC LK LR LS LT<br />

LU LV MA MD MG MK MN MW MX MZ<br />

NO NZ PL PT RO RU SD SE SG SI SK SL<br />

TJ TM TR TT TZ UA UG US UZ VN YU ZA<br />

ZW.<br />

(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />

UG ZW); EA (AM AZ BY KG KZ MD RU<br />

TJ TM); EP (AT BE CH CY DE DK ES FI<br />

FR GB GR IE IT LU MC NL PT SE TR); OA<br />

(BF BJ CF CG CI CM GA GN GW ML MR<br />

NE SN TD TG).<br />

(51) 7 C07D 487/04, A61K 31/519, A61P 7/02 //<br />

(C07D 487/04, 249:00, 239:00)<br />

(11) WO 01/364<strong>21</strong> (13) A1<br />

(<strong>21</strong>) <strong>PCT</strong>/SE00/02229<br />

(22) 14 <strong>No</strong>v/nov 2000 (14.11.2000)<br />

(25) en (26) en<br />

(30) 9904129-5 15 <strong>No</strong>v/nov 1999 SE<br />

(15.11.1999)<br />

(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />

(54) • NOVEL [1,2,3]-TRIAZOLO[4,5-<br />

D]PYRIMIDINE COMPOUNDS<br />

• COMPOSES A BASE DE [1,2,3]-TRIA-<br />

ZOLO[4,5-D]PYRIMIDINE<br />

(71) ASTRAZENECA AB [SE/SE]; S-151 85<br />

Södertälje (SE).<br />

(for all designated States except / pour tous<br />

les États désignés sauf US)<br />

(72, 75) GUILE, Simon [GB/GB]; AstraZeneca<br />

R & D Charnwood, Bakewell Road,<br />

Loughborough, Leics. LE11 5RH (GB).<br />

SPRINGTHORPE, Brian [GB/GB]; AstraZeneca<br />

R & D Charnwood, Bakewell<br />

Road, Loughborough, Leics. LE11 5RH<br />

(GB).<br />

(74) ASTRAZENECA AB; Global Intellectual<br />

Property, S-151 85 Södertälje (SE).<br />

(81) AE AG AL AM AT AU AZ BA BB BG BR<br />

BY BZ CA CH CN CR CU CZ DE DK DM<br />

DZ EE ES FI GB GD GE GH GM HR HU<br />

ID IL IN IS JP KE KG KP KR KZ LC LK<br />

LR LS LT LU LV MA MD MG MK MN MW<br />

MX MZ NO NZ PL PT RO RU SD SE SG SI<br />

SK SL TJ TM TR TT TZ UA UG US UZ VN<br />

YU ZA ZW.<br />

(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />

UG ZW); EA (AM AZ BY KG KZ MD RU<br />

TJ TM); EP (AT BE CH CY DE DK ES FI<br />

FR GB GR IE IT LU MC NL PT SE TR); OA<br />

(BF BJ CF CG CI CM GA GN GW ML MR<br />

NE SN TD TG).<br />

(51) 7 C07D 487/04, 495/14, 491/14, A61K<br />

31/505, A61P 9/12 // (C07D 487/04, 239:00,<br />

231:00) (C07D 495/14, 335:00, 239:00,<br />

231:00) (C07D 491/14, 307:00, 239:00,<br />

231:00)<br />

(11) WO 01/36422 (13) A1<br />

(<strong>21</strong>) <strong>PCT</strong>/US00/32333<br />

(22) 17 <strong>No</strong>v/nov 2000 (17.11.2000)<br />

(25) en (26) en<br />

(30) 09/443,<strong>21</strong>2 19 <strong>No</strong>v/nov 1999 US<br />

(19.11.1999)<br />

(30) 09/709,923 10 <strong>No</strong>v/nov 2000 US<br />

(10.11.2000)<br />

(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />

(54) • TRICYCLIC DIHYDROPYRIMIDINE<br />

POTASSIUM CHANNEL OPENERS<br />

• OUVREURS DE CANAUX POTAS-<br />

SIQUES DU TYPE DIHYDROPYRIMI-<br />

DINE TRICYCLIQUE<br />

(71) ABBOTT LABORATORIES [US/US];<br />

Dept. 377/AP6D-2, 100 Abbott Park Road,<br />

Abbott Park, IL 60064-6050 (US).<br />

(72) HOLLADAY, Mark, W.; 6480 East Placita<br />

Acambay, Tucson, AZ 85750 (US). CAR-<br />

ROLL, William, A.; 2514 Prairie, Apt. 3B,<br />

Evanston, IL 60201 (US). DRIZIN, Irene;<br />

16764 West Cherrywood Lane, Wadsworth,<br />

IL 60083 (US). YI, Lin; 1738 Hillside Court,<br />

Gurnee, IL 60031 (US). ZHANG, Henry, Q.;<br />

107 Suffolk Lane, Grayslake, IL 60030 (US).<br />

(74) WARD, Michael, J. et al. / etc.; Dept.<br />

377/AP6D-2, 100 Abbott Park Road, Abbott<br />

Park, IL 60064-6050 (US).<br />

(81) CA JP MX.<br />

(84) EP (AT BE CH CY DE DK ES FI FR GB GR<br />

IE IT LU MC NL PT SE TR).<br />

(51) 7 C07D 491/107, A61K 31/445, A61P 25/00<br />

(11) WO 01/36423<br />

(<strong>21</strong>) <strong>PCT</strong>/EP00/11351<br />

(13) A1<br />

(22) 13 <strong>No</strong>v/nov 2000 (13.11.2000)<br />

(25) en (26) en<br />

(30) 99309137.0 17 <strong>No</strong>v/nov 1999<br />

(17.11.1999)<br />

EP<br />

(43) 25 May/mai <strong>2001</strong> (25.05.<strong>2001</strong>)<br />

(54) • SPIRO(2H-1-BENZOPYRAN-2,4’-<br />

PIPERIDINE) DERIVATES AS<br />

GLYCINE TRANSPORT INHIBITORS<br />

• DERIVES DE SPIRO(2H-1-BENZO-<br />

PYRAN-2,4’-PIPERIDINE) EN TANT<br />

QU’INHIBITEURS<br />

DE GLYCINE<br />

DE TRANSPORT<br />

(71) AKZO NOBEL N.V. [NL/NL]; Velperweg<br />

76, NL-6824 BM Arnhem (NL).<br />

(for all designated States except / pour tous<br />

les États désignés sauf US)<br />

(72, 75) GIBSON, Samuel, George [GB/GB];<br />

19 Ross Crescent, Motherwell, Lanarkshire<br />

ML1 3AU (GB). MILLER, David, John

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!